ALGAE.PA
SellSinkerFermentalg SA · Healthcare · France · $64M · Avg Vol: $29K/d
Sinker: Weak, expensive and falling. Nothing here to keep it afloat.
21
StockRankGet insider-trade alerts
QualityQuality
24
ValueValue
34
MomentumMomentum
47
P/E (TTM)
—
peers 22.9x
ROE
-32.6%
peers -42.5%
D/E
0.2x
peers 0.4x
Dividend %
—
trailing yield
ABOUT FERMENTALG SA
Read
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally.
FINANCIAL SUMMARY (EUR)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 7.6M | 4.1M | 11.5M | 13.4M | 20.5% | 13.4M | 19.4M | 33.1M | 57.1% |
| EPS (EUR) | — | -0.09 | -0.14 | -0.17 | -0.09 | — | -0.09 | -0.08 | -0.04 | — |
| Shares | 40.0M | 113.4M | 113.4M | 90.5M | 96.1M | +140.4% | 119.8M | — | — | — |
| Debt | — | 11.0M | 15.4M | 12.6M | 5.0M | -23.0% | 5.0M | — | — | — |
| Equity | — | 42.0M | 30.8M | 32.8M | 25.2M | -15.7% | — | — | — | — |
| Op CF | — | -8.2M | -8.7M | -0.5M | -6.6M | — | -6.6M | — | — | — |
| Inv CF | — | -7.3M | -1.8M | -1.1M | -1.8M | — | — | — | — | — |
| Fin CF | — | 5.4M | 5.7M | 11.1M | -5.6M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-3.9%
SMA 50SMA 200
Close
$0.5199
RSI (14)
47.6
52W High
$0.7354
From 52W High
0.7%
SCORE BREAKDOWN
Quality
24
ROIC
-30.3%24.5
ROE
-32.6%24.5
GP/Assets
6.2%19.7
Op. Margin
-100.2%17.0
FCF/Assets
-22.3%19.1
Piotroski
316.0
Int. Cover
-19.9x17.6
D/E Ratio
0.20x49.9
Current Ratio
1.96x38.5
Value
34
P/E (TTM)
—N/A
EV/EBITDA
-4.6x25.0
P/FCF
—N/A
P/B
1.7x67.4
P/S
4.0x47.0
Div Yield
—N/A
Momentum
47
52W High %
71%52.0
RS 6M
-7%56.5
SMA 50/200
0.99x55.2
EPS Rev 4W
-0.9%25.2
EPS Rev 12W
—N/A
EPS Improve
+56%57.7
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$64M
P/E (Forward)
-11.2x
Gross Margin
17.1%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALGAE.PA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ALGAE.PA | Fermentalg SA(you) | $64M | 21 | Sell |
| ALTHX.PA | THX Pharma Société Anonyme | $71M | 9 | Strong Sell |
| OSE.PA | OSE Immunotherapeutics SA | $89M | 4 | Strong Sell |
| ADOC.PA | Adocia SA | $94M | 0 | Strong Sell |
| ABNX.PA | ABIONYX Pharma SA | $100M | 1 | Strong Sell |
| TNG.PA | Transgene SA | $259M | 18 | Strong Sell |
| IPH.PA | Innate Pharma S.A. | $243M | 17 | Strong Sell |
| ALSEN.PA | Sensorion SA | $162M | 3 | Strong Sell |
| CLLS | Cellectis S.A. | $342M | 6 | Strong Sell |
| VALN | Valneva SE | $610M | 12 | Strong Sell |
Peer medians: ROE -42.5% · P/E 22.9x · Gross margin 73.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.